Maharashtra deputy chief minister Eknath Shinde has directed the state health department to include rare diseases under the Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY), according to a statement. The move is aimed at ensuring timely diagnosis and effective treatment for patients with rare diseases such as Spinal Muscular Atrophy (SMA) and at shielding their families from the financial burden of expensive medical care.

Shinde also asked the department to prepare a comprehensive standard operating procedure for treating SMA patients and to strengthen early diagnosis, patient registration and treatment processes. The directions followed a Wednesday meeting at which officials discussed the current status of SMA patients in Maharashtra, diagnosis of the disease, available treatment options, availability of medicines and the challenges patients face.

The central government has selected KEM Hospital in Mumbai as the Centre of Excellence for Maharashtra. The centre handles diagnosis of rare diseases, patient registration and related treatment procedures, but a clearly defined protocol is necessary so that patients receive treatment more easily and in time.

Treatment facilities for SMA are also available at Wadia Children's Hospital in Mumbai. Shinde directed the health department to prepare a proposal and send it to the Union health ministry to secure Centre of Excellence status for the hospital as well, saying he will personally write to the Union health minister and follow up on the matter. He also said KEM Hospital should add the essential medicines required for treating the disease to its essential medicines list and procure them accordingly.